Invitrogen™ Human BID ELISA Kit

Ref.: BL-RE-092174Manufacturer ref.: EH44RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human BID quantitates human BID in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human BID.

Accession number
2700049M22Rik ; AI875481 ; apoptique d ; agoniste de mort apoptique ; agoniste BID de mort apoptotique ; AU022477 ; agoniste de mort de domaine interagissant avec BH3 ; agoniste de mort de domaine interagissant avec BH3 ; agoniste p11 de mort de domaine interagissant avec BH3 ; agoniste p13 de mort de domaine interagissant avec BH3 ; Bid ; BID isoforme ES(1 b) ; BID isoforme L(2) ; BID isoforme Si6 ; desmocolline type 4 ; FP497 ; HGNC:1050 ; séquence de codage de BID humain ; MGC15319 ; MGC42355 ; OTTHUMP00000196197 ; p11 BID ; p13 BID ; p15 BID ; p22 BID
Dose range
3.2 to 300 ng/ml
Sensitivity of the dosage
3.2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human BID quantitates human BID in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human BID.

Human BID quantitates human BID in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human BID.

The IDB is a death agonist who heterodimerizes with the BAX or the BCL2 antagonist. Bid is a member of the BCL-2 family of cell death regulators. BID is a mediator of the mitochondrial damage induced by caspase-8 (CASP8); CASP8 clives this coded protein and the terminal part of COOH transits to mitochondria where it triggers the release of cytochrome c. The IDB is also a pro-apoptotic member of the Bcl 2 family. BID usually exists in an inactive form in the cytosolic fraction of living cells and is cleaved and activated by caspase 8 in response to TNF alpha or Fas ligand. Once the IDB is cleaved, the 15 kDa C-terminal fragment of the IDB (p15) moves over the mitochondria and is sufficient to trigger the release of cytochrome c, resulting in cell apoptosis. The IDB serves as a direct molecular link between activation of caspase 8 and mitochondrial death machines.

Sensitivity

Sensitivity of dosage: 3.2 ng/ml.

Measurement range

Dose range: 3.2 to 300 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: BID.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17115239
Specifications
Accession number2700049M22Rik; AI875481 ; apoptic d ; apoptic death agonist ; BID agonist of apoptotic death ; AU022477 ; domain death agonist interacting with BH3 ; domain death agonist interacting with BH3 ; domain death agonist interacting with BH3 ; death agonist p13
Dose range3.2 to 300 ng/ml
Sensitivity of the dosage3.2 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P55957
Gene symbol(s)BID
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetBID
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH44RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.